Regenerative Medicine: The Cornea

How three leading lights and one CEO are tackling corneal disease through pioneering research and development

September 2017

Ophthalmology is at the forefront of many fields of biomedicine, including diagnostics, drug development, and gene therapy. Understandably so – despite all of the incredible advances in eyecare over the last 50 years, there’s still a huge unmet need for sight-saving and sight-restoring interventions. If new or better therapies can be developed that meet these needs, particularly within the context of aging baby boomers with age-related eye disease, it will be of huge benefit to healthcare systems and society. Another field that vision science is trailblazing is regenerative medicine. Many research groups are focused on treating retinal diseases with cell therapy and have rightly received a great deal of coverage. But what about the cornea? We caught up with three leading researchers and one CEO to find out how they are approaching corneal repair and regeneration, and how these potentially life-changing therapies are being brought to patients.

From Liposuction to New Stromal Collagen Production

Resurrecting the Cornea

Collaboration of Culture

Enjoy our FREE content!

Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!

If you don’t have an account you can:

REGISTER NOW – it’s FREE and always will be!

You will benefit from:

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Ophthalmologist magazine

Or Login as a Guest or via Social Media

This will allow you to read this article but you will only have limited access to The Ophthalmologist.

About the author

Mark Hillen

Before joining Texere Publishing as Editor of The Ophthalmologist, I spent seven years as a medical writer, writing primary and review manuscripts, congress presentations and marketing materials for numerous – and mostly German – pharmaceutical companies. Prior to my adventures in medical communications, I was a Wellcome Trust PhD student at the University of Edinburgh, where I examined mouse brain development. I miss my labcoat, pipette, peristaltic pumps and PCR machines, but I have grown to love my laptop, keyboard, mouse and rotating monitors even more.

About this Article

Published in Issue #0917

Welcome to the September issue of The Ophthalmologist! Upfront’s topics include how art training can improve ophthalmologists’ observational skills, and how patients with AMD really feel about their disease. In My View sees Simon Skalicky make the case for effective glaucoma counselling, and Bobeck Modjtahedi discusses how ophthalmologists should look beyond the eyes when caring for their patients. In our multi-article Feature, we visit the topic of regenerative medicine for the cornea, and hear from some of the leaders in the field. NextGen sees Michael Larsen discuss how assessing dark adaptation could lead to earlier diagnosis of AMD, and in Profession, we take a tour of Orbis’ new Flying Eye Hospital. Finally, we Sit Down With Richard Lindstrom, Chairman and Founder of Minnesota Eye Consultants, Minneapolis, Minnesota, USA.

Feature

Feature articles probe and discuss topics in greater depth by gaining insight from leading Ophthalmologists and industry figures.

These articles allow in-depth coverage of the people, societies, devices and therapies that advance Ophthalmology as a whole, and reinforce the importance of the role Ophthalmologists play in saving the vision of tens of millions of people worldwide each year.

We welcome suggestions for Feature topics and, upon agreement, contributions to the section.

Please email edit@texerepublishing.com

Enjoy our FREE content!

Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!

If you don’t have an account you can:

Related Articles